3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Hematologic Neoplasms
1
Hematologic Diseases
1
Interventions
fludarabine
3
Cyclophosphamide
3
Busulfan
2
venetoclax
1
trametinib
1
luspatercept
1
gilteritinib
1
dabrafenib
1
Whole-Body Irradiation
1
Vancomycin
1
Thiotepa
1
Teicoplanin
1
Tacrolimus
1
Stem Cell Transplantation
1
Rituximab
1
Radiosurgery
1
Ofloxacin
1
NF protocol
1
Mycophenolic Acid
1
Metronidazole
1
Meropenem
1
Kidney Transplantation
1
Granulocyte Colony-Stimulating Factor
1
Genetic Testing
1
Cytarabine
1
Complementary Therapies
1
Ciprofloxacin
1
Ceftazidime
1
Cefepime
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Hematologic Neoplasms
×
Complementary Therapies
×
Clear all
NCT07541326
2026-04-21
COMPLHEMATO
University Hospital, Limoges
Phase NA
Not yet recruiting
85 enrolled